Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q3
Sell
-4,509
Closed -$831K 178
2019
Q2
$831K Sell
4,509
-164
-4% -$29.4K 0.68% 41
2019
Q1
$888K Sell
4,673
-8
-0.2% -$1.53K 0.77% 41
2018
Q4
$911K Buy
4,681
+318
+7% +$62K 0.9% 24
2018
Q3
$904K Sell
4,363
-451
-9% -$88.9K 0.73% 39
2018
Q2
$889K Sell
4,814
-265
-5% -$46.9K 0.55% 41
2018
Q1
$866K Buy
+5,079
New +$932K 0.48% 51
2016
Q3
Sell
-1,320
Closed -$201K 148
2016
Q2
$201K Sell
1,320
-987
-43% -$153K 0.14% 178
2016
Q1
$346K Sell
2,307
-30
-1% -$4.46K 0.23% 101
2015
Q4
$379K Sell
2,337
-73
-3% -$11.5K 0.26% 96
2015
Q3
$333K Sell
2,410
-52
-2% -$8.2K 0.24% 110
2015
Q2
$378K Sell
2,462
-188
-7% -$30.1K 0.25% 108
2015
Q1
$424K Sell
2,650
-8
-0.3% -$1.26K 0.25% 97
2014
Q4
$423K Buy
+2,658
New +$414K 0.23% 88
2013
Q3
Sell
-9,025
Closed -$890K 120
2013
Q2
$890K Buy
+9,025
New +$937K 0.41% 54

Other funds holding AMGN

Miles Capital's AMGN Position: Q3 2019 in Review

Miles Capital sold out of Amgen (AMGN) in Q3 2019, closing a stake of 4,509 shares — an estimated $831K sold.

Miles Capital first reported a position in AMGN in Q2 2013 and held it in 14 quarters. The position peaked at $911K in Q4 2018. 1,884 funds tracked by Wall St. Rank hold AMGN as of Q3 2019.

  • Miles Capital reported no remaining Amgen position as of Q3 2019 after selling out during the quarter.
  • Miles Capital sold 4,509 Amgen shares in Q3 2019, an estimated $831K.
  • Miles Capital first reported a position in Amgen in Q2 2013 and held it in 14 quarters.
  • Miles Capital's Amgen position peaked at $911K in Q4 2018.
  • 1,884 funds tracked by Wall St. Rank held Amgen as of Q3 2019.

Based on Miles Capital's 13F filing for Q3 2019, filed 7 Nov 2019.